HLA-C and cancer: Due to the increased neoantigens produced by somatic tumor mutations, the higher the number of mutations (higher the TMB), the higher the likelihood that certain neoantigens presented by MHC proteins are immunogenic and thus can help T cells to recognize and eradicate cancer cells [29].